Search Results - "Ruswa, Nunurai"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia by Günther, Gunar, Mhuulu, Lusia, Diergaardt, Azaria, Dreyer, Viola, Moses, Maria, Anyolo, Kaarna, Ruswa, Nunurai, Claassens, Mareli, Niemann, Stefan, Nepolo, Emmanuel

    Published in Emerging infectious diseases (01-03-2024)
    “…Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of…”
    Get full text
    Journal Article
  2. 2

    Enhanced active case finding of drug-resistant tuberculosis in Namibia: a protocol for the hotspots, hospitals, and households (H3TB) study by Shavuka, Olga, Iipumbu, Etuhole, Boois, Lorraine, Günther, Gunar, Hoddinott, Graeme, Lin, Hsien-Ho, Nepolo, Emmanuel, Niemann, Stefan, Ruswa, Nunurai, Seddon, James, Claassens, Mareli M

    Published in BMJ open (10-02-2024)
    “…IntroductionNamibia is a high tuberculosis (TB)-burden country with an estimated incidence of 460/100 000 (around 12 000 cases) per year. Approximately 4.5% of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Drug-Resistant Tuberculosis Case-Finding Strategies: Scoping Review by van Wyk, Susanna S, Nliwasa, Marriott, Lu, Fang-Wen, Lan, Chih-Chan, Seddon, James A, Hoddinott, Graeme, Viljoen, Lario, Günther, Gunar, Ruswa, Nunurai, Shah, N Sarita, Claassens, Mareli

    Published in JMIR public health and surveillance (26-06-2024)
    “…Finding individuals with drug-resistant tuberculosis (DR-TB) is important to control the pandemic and improve patient clinical outcomes. To our knowledge,…”
    Get full text
    Journal Article
  5. 5

    Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study by Sagwa, Evans L, Mantel-Teeuwisse, Aukje K, Ruswa, Nunurai C

    “…To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and…”
    Get full text
    Journal Article
  6. 6

    Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review by Van Wyk, Susanna S, Nliwasa, Marriott, Seddon, James A, Hoddinott, Graeme, Viljoen, Lario, Nepolo, Emmanuel, Günther, Gunar, Ruswa, Nunurai, Lin, Hsien-Ho, Niemann, Stefan, Gandhi, Neel R, Shah, N Sarita, Claassens, Mareli

    Published in JMIR research protocols (15-12-2022)
    “…Transmission of drug-resistant tuberculosis (DR-TB) is ongoing. Finding individuals with DR-TB and initiating treatment as early as possible is important to…”
    Get full text
    Journal Article
  7. 7

    Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia by Kibuule, Dan, Aiases, Philomein, Ruswa, Nunurai, Rennie, Timothy William, Verbeeck, Roger K, Godman, Brian, Mubita, Mwangana

    Published in ERJ open research (01-01-2020)
    “…In Namibia, one out of every 25 cases of tuberculosis (TB) is "lost to follow-up" (LTFU). This has impacted negatively on national efforts to end the disease…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Drug-resistant tuberculosis: advances in diagnosis and management by Günther, Gunar, Ruswa, Nunurai, Keller, Peter M.

    Published in Current opinion in pulmonary medicine (01-05-2022)
    “…Diagnosis and treatment of drug-resistant tuberculosis (DR-TB) is undergoing substantial changes, owing availability of new diagnostic tools and drugs, coupled…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection by Sagwa, Evans, Ruswa, Nunurai, Musasa, Jean Paul, Mantel-Teeuwisse, Aukje K.

    Published in Drug safety (01-11-2013)
    “…Introduction In settings such as Namibia with a high prevalence of human immunodeficiency virus (HIV) and drug-resistant (DR) tuberculosis (TB) co-infection,…”
    Get full text
    Journal Article
  12. 12

    Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort by Sagwa, Evans L, Ruswa, Nunurai, Mavhunga, Farai, Rennie, Timothy, Leufkens, Hubert G M, Mantel-Teeuwisse, Aukje K

    Published in BMC pharmacology & toxicology (10-12-2015)
    “…Amikacin and kanamycin are mainly used for treating multidrug-resistant tuberculosis (MDR-TB), especially in developing countries where the burden of MDR-TB is…”
    Get full text
    Journal Article
  13. 13

    Predictors of tuberculosis treatment success under the DOTS program in Namibia by Kibuule, Dan, Verbeeck, Roger K, Nunurai, Ruswa, Mavhunga, Farai, Ene, Ette, Godman, Brian, Rennie, Timothy W

    Published in Expert review of respiratory medicine (02-11-2018)
    “…Optimal treatment success rates are critical to end tuberculosis in Namibia. Despite the scale-up of high quality directly observed therapy short-course…”
    Get more information
    Journal Article
  14. 14

    Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys by Hamada, Yohhei, Quartagno, Matteo, Law, Irwin, Malik, Farihah, Bonsu, Frank Adae, Adetifa, Ifedayo M O, Adusi-Poku, Yaw, D'Alessandro, Umberto, Bashorun, Adedapo Olufemi, Begum, Vikarunnessa, Lolong, Dina Bisara, Boldoo, Tsolmon, Dlamini, Themba, Donkor, Simon, Dwihardiani, Bintari, Egwaga, Saidi, Farid, Muhammad N, Celina G Garfin, Anna Marie, Mae G Gaviola, Donna, Husain, Mohammad Mushtuq, Ismail, Farzana, Kaggwa, Mugagga, Kamara, Deus V, Kasozi, Samuel, Kaswaswa, Kruger, Kirenga, Bruce, Klinkenberg, Eveline, Kondo, Zuweina, Lawanson, Adebola, Macheque, David, Manhiça, Ivan, Maama-Maime, Llang Bridget, Mfinanga, Sayoki, Moyo, Sizulu, Mpunga, James, Mthiyane, Thuli, Mustikawati, Dyah Erti, Mvusi, Lindiwe, Nguyen, Hoa Binh, Nguyen, Hai Viet, Pangaribuan, Lamria, Patrobas, Philip, Rahman, Mahmudur, Rahman, Mahbubur, Rahman, Mohammed Sayeedur, Raleting, Thato, Riono, Pandu, Ruswa, Nunurai, Rutebemberwa, Elizeus, Rwabinumi, Mugabe Frank, Senkoro, Mbazi, Sharif, Ahmad Raihan, Sikhondze, Welile, Sismanidis, Charalambos, Sovd, Tugsdelger, Stavia, Turyahabwe, Sultana, Sabera, Suriani, Oster, Thomas, Albertina Martha, Tobing, Kristina, Van der Walt, Martie, Walusimbi, Simon, Zaman, Mohammad Mostafa, Floyd, Katherine, Copas, Andrew, Abubakar, Ibrahim, Rangaka, Molebogeng X

    Published in EClinicalMedicine (01-09-2023)
    “…Non-communicable diseases (NCDs) and NCD risk factors, such as smoking, increase the risk for tuberculosis (TB). Data are scarce on the risk of prevalent TB…”
    Get full text
    Journal Article
  15. 15

    Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys: Time for household-wide interventions? by Hamada, Yohhei, Quartagno, Matteo, Law, Irwin, Malik, Farihah, Bonsu, Frank Adae, Adetifa, Ifedayo M O, Adusi-Poku, Yaw, D'Alessandro, Umberto, Bashorun, Adedapo Olufemi, Begum, Vikarunnessa, Lolong, Dina Bisara, Boldoo, Tsolmon, Dlamini, Themba, Donkor, Simon, Dwihardiani, Bintari, Egwaga, Saidi, Farid, Muhammad N, Garfin, Anna Marie Celina G, Gaviola, Donna Mae G, Husain, Mohammad Mushtuq, Ismail, Farzana, Kaggwa, Mugagga, Kamara, Deus V, Kasozi, Samuel, Kaswaswa, Kruger, Kirenga, Bruce, Klinkenberg, Eveline, Kondo, Zuweina, Lawanson, Adebola, Macheque, David, Manhiça, Ivan, Maama-Maime, Llang Bridget, Mfinanga, Sayoki, Moyo, Sizulu, Mpunga, James, Mthiyane, Thuli, Mustikawati, Dyah Erti, Mvusi, Lindiwe, Nguyen, Hoa Binh, Nguyen, Hai Viet, Pangaribuan, Lamria, Patrobas, Philip, Rahman, Mahmudur, Rahman, Mahbubur, Rahman, Mohammed Sayeedur, Raleting, Thato, Riono, Pandu, Ruswa, Nunurai, Rutebemberwa, Elizeus, Rwabinumi, Mugabe Frank, Senkoro, Mbazi, Sharif, Ahmad Raihan, Sikhondze, Welile, Sismanidis, Charalambos, Sovd, Tugsdelger, Stavia, Turyahabwe, Sultana, Sabera, Suriani, Oster, Thomas, Albertina Martha, Tobing, Kristina, Van der Walt, Martie, Walusimbi, Simon, Zaman, Mohammad Mostafa, Floyd, Katherine, Copas, Andrew, Abubakar, Ibrahim, Rangaka, Molebogeng X

    Published in PLOS global public health (2024)
    “…Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB…”
    Get full text
    Journal Article
  16. 16

    Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveysResearch in context by Yohhei Hamada, Matteo Quartagno, Irwin Law, Farihah Malik, Frank Adae Bonsu, Ifedayo M.O. Adetifa, Yaw Adusi-Poku, Umberto D'Alessandro, Adedapo Olufemi Bashorun, Vikarunnessa Begum, Dina Bisara Lolong, Tsolmon Boldoo, Themba Dlamini, Simon Donkor, Bintari Dwihardiani, Saidi Egwaga, Muhammad N. Farid, Anna Marie Celina G.Garfin, Donna Mae G Gaviola, Mohammad Mushtuq Husain, Farzana Ismail, Mugagga Kaggwa, Deus V. Kamara, Samuel Kasozi, Kruger Kaswaswa, Bruce Kirenga, Eveline Klinkenberg, Zuweina Kondo, Adebola Lawanson, David Macheque, Ivan Manhiça, Llang Bridget Maama-Maime, Sayoki Mfinanga, Sizulu Moyo, James Mpunga, Thuli Mthiyane, Dyah Erti Mustikawati, Lindiwe Mvusi, Hoa Binh Nguyen, Hai Viet Nguyen, Lamria Pangaribuan, Philip Patrobas, Mahmudur Rahman, Mahbubur Rahman, Mohammed Sayeedur Rahman, Thato Raleting, Pandu Riono, Nunurai Ruswa, Elizeus Rutebemberwa, Mugabe Frank Rwabinumi, Mbazi Senkoro, Ahmad Raihan Sharif, Welile Sikhondze, Charalambos Sismanidis, Tugsdelger Sovd, Turyahabwe Stavia, Sabera Sultana, Oster Suriani, Albertina Martha Thomas, Kristina Tobing, Martie Van der Walt, Simon Walusimbi, Mohammad Mostafa Zaman, Katherine Floyd, Andrew Copas, Ibrahim Abubakar, Molebogeng X. Rangaka

    Published in EClinicalMedicine (01-09-2023)
    “…Background: Non-communicable diseases (NCDs) and NCD risk factors, such as smoking, increase the risk for tuberculosis (TB). Data are scarce on the risk of…”
    Get full text
    Journal Article
  17. 17

    Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia by Sagwa, Evans L, Ruswa, Nunurai, Mavhunga, Farai, Rennie, Timothy, Leufkens, Hubert Gm, Mantel-Teeuwisse, Aukje K

    Published in Patient preference and adherence (01-01-2016)
    “…The health-related quality of life (HRQoL) of patients completing multidrug-resistant tuberculosis (MDR-TB) treatment in Namibia and whether the occurrence of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia by Sagwa, Evans, Mantel-Teeuwisse, Aukje Kaija, Ruswa, Nunurai, Musasa, Jean Paul, Pal, Shanthi, Dhliwayo, Panganai, van Wyk, Brian

    Published in Southern med review (01-07-2012)
    “…Namibia faces a dual burden of HIV/AIDS and tuberculosis (TB). In 2010, HIV prevalence was 18.8%, the TB case notification rate was 634 cases per 100,000…”
    Get full text
    Journal Article